Corxel Pharmaceuticals

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
Optimizing Reperfusion to Improve Outcomes and Neurologic Function	Acute Ischemic Stroke, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder	Recruiting	Phase 2 / Phase 3	2026-09-21	NCT06990867
A Food-Effect Study of CX11 in Healthy Participants	Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, nutritional disorder, obesity disorder, overnutrition, type 2 diabetes mellitus	Active, not recruiting	Phase 1	2026-09-16	NCT07349381
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus	Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hypoglycemia, metabolic disease, type 2 diabetes mellitus	Recruiting	Phase 2	2026-09-15	NCT07340320
A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 Tablets	Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition	Recruiting	Phase 1	2026-06-17	NCT07652047

Clinical trials